Searched for
PHARMA IPO 2026
We expect interest rates to be left the way they are: Ficci chief Anant GoenkaFicci president Anant Goenka advocates for steady interest rates, citing supply-side price pressures from the West Asia crisis. He suggests...- IPO investors brace for 70 lock-in expiries worth $35 billion in three months. Do you own any?According to Nuvama Alternative & Quantitative Research, the Indian stock market is set to witness a significant wave of lock-in expiries b...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...
- Fractal Analytics Q4 Results: Profit more than doubles to Rs 116 croreFractal Analytics reported a significant financial leap, with its Q4 profit after tax doubling to Rs 116 crore, fueled by an impressive 82%...
- Are metals turning defensive? 5-year returns rival, even beat traditional safe havensMetal stocks are outperforming defensive sectors, delivering strong returns driven by structural demand shifts and supply constraints. Fact...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- The Big Review: Markets near bottom, selective opportunities emerging for FY27HDFC Securities report highlights India’s macro stability despite global risks, with steady growth, moderating inflation and controlled fis...
- Speciality Medicines IPO: SME stock to list today. Check price band, other detailsSpeciality Medicines shares debut on the BSE SME platform today. The company's IPO, a fresh issue, sought to raise approximately Rs 29 cror...
- Sai Parenteral IPO Day 3: 43% subscribed; here’s a look at GMP and key details; Should you invest?Sai Parenteral IPO saw 43% subscription on Day 3, with strong NII interest but weak retail participation. Despite no GMP indicating a flat ...
- Speciality Medicines IPO opens for subscription. Check price band, GMP, subscription and other detailsSpeciality Medicines' IPO opens Friday, aiming to raise Rs 29 crore with a flat 0% grey market premium, indicating cautious investor sentim...
- After a disguised bear market in 2025, 3 sectors in focus as 2026 promises better returns: Dipan MehtaMarket veteran Dipan Mehta expects 2026 to be a turnaround year for Indian equities after a tough 2025. He highlights autos, IT services, p...
- Follow the ‘Dharma of Asset Allocation’, says Nilesh Shah; sees midcaps outperforming in 2026India market outlook 2026: Kotak AMC MD Nilesh Shah advises disciplined asset allocation as equity returns hinge on earnings growth. Gold a...
- ETMarkets Smart Talk | From liquidity to earnings: Why 2026 will be a stock-picker’s market, Nikhil Khandelwal decodesIndian equities enter 2026 on a mature footing, shifting from liquidity-driven gains to an earnings-focused environment. Investors must pri...
- HDFC Mutual Fund: Eternal, ITC, Swiggy, and Paytm among stocks bought and sold in NovemberHDFC Mutual Fund increased its holdings in 469 stocks in November, adding exposure to names such as Eternal, ITC, ICICI Bank and Infosys, w...
- Health makes wealth, says Equirus, as healthcare fundraising crosses pre-Covid high of Rs 62,432 croreIndia’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equir...
- Sudeep Pharma sees healthy GMP: How to check IPO allotment on MUFG Intime India and BSE?Investors will know their Sudeep Pharma IPO allotment status on Wednesday. The offering saw strong demand. Grey market activity suggests a ...
- Will Sudeep Pharma’s IPO stand out as a long-term growth opportunity?Sudeep Pharma plans to raise ₹95 crore for capex and expand manufacturing capacity by 50,000 tonnes by March 2026. Despite strong export re...
- Curis Lifesciences IPO opens for subscription. Check GMP and other details before investingCuris Lifesciences launched its Rs 27.5 crore SME IPO on November 7, aiming to raise funds for infrastructure expansion and working capital...
- IPO Calendar: September to take forward IPO momentum with 7 new issues, 15 listings in first weekSeptember opens with strong IPO momentum, featuring seven new issues and 15 listings in the first week. While SME offerings dominate with s...
- Stocks in news: IndusInd Bank, Adani Green, Kotak Bank, NTPC Green, Ola ElectricIndian markets closed lower for the fourth consecutive week amid mixed signals. Several companies like IndusInd Bank and Adani Green remain...
Load More
